APA (7th ed.) Citation

H, D., X, L., N, S., L, L., X, H., H, G., . . . S, L. (2019). Proprotein convertase subtilisin/kexin 9 inhibitors in reducing cardiovascular outcomes: A systematic review and meta-analysis. Heart (British Cardiac Society), 105(15), 1149. https://doi.org/10.1136/heartjnl-2019-314763

Chicago Style (17th ed.) Citation

H, Du, et al. "Proprotein Convertase Subtilisin/kexin 9 Inhibitors in Reducing Cardiovascular Outcomes: A Systematic Review and Meta-analysis." Heart (British Cardiac Society) 105, no. 15 (2019): 1149. https://doi.org/10.1136/heartjnl-2019-314763.

MLA (9th ed.) Citation

H, Du, et al. "Proprotein Convertase Subtilisin/kexin 9 Inhibitors in Reducing Cardiovascular Outcomes: A Systematic Review and Meta-analysis." Heart (British Cardiac Society), vol. 105, no. 15, 2019, p. 1149, https://doi.org/10.1136/heartjnl-2019-314763.